Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

ABEONA THERAPEUTICS ($ABEO) Releases Q1 2026 Earnings

None

ABEONA THERAPEUTICS ($ABEO) posted quarterly earnings results for Q1 2026 on Wednesday, May 13th. The company reported earnings of -$0.30 per share, beating estimates of -$0.36 by $0.06. The company also reported revenue of $8,720,000, beating estimates of $4,663,001 by $4,056,999.

You can see Quiver Quantitative's $ABEO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

EARLY ACCESS
Receive ABEO Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

ABEONA THERAPEUTICS Insider Trading Activity

ABEO Insider Trades

ABEONA THERAPEUTICS insiders have traded $ABEO stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $ABEO stock by insiders over the last 6 months:

  • VISHWAS SESHADRI (Chief Executive Officer) has made 0 purchases and 3 sales selling 124,817 shares for an estimated $636,488.
  • MARK ALVINO has made 0 purchases and 2 sales selling 28,500 shares for an estimated $141,741.
  • JOSEPH WALTER VAZZANO (Chief Financial Officer) has made 0 purchases and 2 sales selling 19,451 shares for an estimated $103,243.
  • CHRISTINE BERNI SILVERSTEIN sold 20,070 shares for an estimated $102,168
  • ERIC CROMBEZ sold 16,284 shares for an estimated $82,895
  • DONALD A. WUCHTERL sold 14,814 shares for an estimated $75,412
  • BRENDAN M. O'MALLEY (SVP, Chief Legal Officer) sold 13,578 shares for an estimated $72,382
  • MADHAV VASANTHAVADA (Chief Commercial Officer) sold 12,610 shares for an estimated $66,657

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

ABEONA THERAPEUTICS Hedge Fund Activity

We have seen 53 institutional investors add shares of ABEONA THERAPEUTICS stock to their portfolio, and 53 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles